Therefore, these results verify that DHODH inhibition can cooperate with cisplatin to inhibiting cervical cancer in a ferroptotic way and the combination exerts a critical therapeutic potential in treating cervical cancer. The gene discussed is DHODH; the disease is cervical cancer.